Though many other states besides Maine are taking targeted actions to lower drug prices, few if any are seeking to tackle the issue in such a comprehensive way.
One study found that plastic and maxillofacial surgeons billed their services out-of-network 23% of the time, more than any of the other 50 specialties analyzed.
Three-quarters of the public, including a majority of Republicans, want the federal government to protect patients from being stuck with surprise medical bills.
“I wish I would have known. I would have said ‘no’ to life support,” said Debbie Moehnke, a former cocktail waitress. “We’ll lose everything.”
For one patient, a three-month supply of insulin is $3,700 in the U.S. versus $600 in Mexico. But is it legal?
Some insurers defend PBMs, arguing that blaming them for high drug prices is unfair when drug companies are free to set their prices as high as they want.
Lawmakers on both sides of the aisle expressing optimism about attacking a problem that has affected 57 percent of American adults,